Navigation Links
Olive Fertility Centre Physician Recognized for Excellence
Date:4/3/2013

Vancouver, Canada (PRWEB) April 03, 2013

Olive Fertility Centre is proud to announce that co-founder and co-director Dr. Jason Hitkari has been awarded the Outstanding Educator Award on behalf of the UBC medical class of 2014 for his contribution as Reproduction Week chair and lecturer. This is the second time Dr. Hitkari has received this award acknowledging the recipient for “extraordinary commitment to teaching and making a significant contribution to learning.”

“This award is a tremendous honour,” says Dr. Hitkari. “Reproductive Endocrinology is an exciting and rapidly changing field. And just as our technology is advancing, so is our model of patient care. As a practicing fertility doctor and educator, I am delighted to have the opportunity to share my experience and insight into fertility treatment with this talented group of future physicians.”

Dr. Hitkari is currently extremely involved in medical student education in reproduction and infertility at UBC. He also coordinates the Reproduction Seminars for the Obstetrics and Gynecology resident physicians and lectures extensively throughout BC to family practitioners, family practice residents, allied health professionals, and gynecologists.

After completing his training in Obstetrics and Gynecology at the University of British Columbia, Dr. Hitkari went on to do a formal fellowship in Reproductive Endocrinology and Infertility at Mt. Sinai Hospital in Toronto. He then returned to Vancouver, where he joined Genesis Fertility Centre as a co-director. In 2013, Dr. Hitkari left Genesis to open a new clinic, Olive Fertility Centre, with Drs. Taylor, Yuzpe, and Fluker.

“Olive Fertility Centre has been up and running since January 2013, but we are looking forward to moving into our brand new clinic at City Square in Vancouver in June 2013. We have some of the most experienced fertility specialists in Canada as part of our physician team, and we ar
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Olive Dental Group Announces a New Treatment for Sleep Apnea
2. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
3. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug
4. d’Oliveira & Associates Seeks Clients That Have Been Affected by the Prescription Drug Topamax
5. d'Oliveira & Associates Offers “No Win - No Fee Promise” on Topamax Cases
6. Explaining how extra virgin olive oil protects against Alzheimers disease
7. d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees
8. d'Oliveira & Associates Helps Massachusetts Man Receive $100,000 in Auto Accident Settlement
9. D’Oliveira & Associates Helps Woonsocket, RI Man Receive Over $38,000 in Back Due Benefits
10. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
11. d’Oliveira & Associates Releases New Webpage on Pradaxa Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Ohio (PRWEB) July 31, 2014 In ... that the pharmaceutical giant, Johnson & Johnson, is withdrawing ... it can spread undetected cancer. This important story ... (7/30), USA Today (7/31), the AP (7/30), the Pittsburgh ... morcellator tool is used during uterine procedures to, “slice ...
(Date:7/31/2014)... , Rest assured, there is a happy ending, ... shows that many college students are stressed out and ... there are simple ways for students to relieve stress ... of UC,s Health Promotion and Education Program. The trouble ... a whole array of different stress-management techniques college students ...
(Date:7/31/2014)... July 31, 2014 The Never Give Up ... supporters from11:00am-11:00pm on August 7th. Simply bring your ticket ... great food and beverages with friends and family. ... His amazing passion and contagious optimism continues to impact ... positive attitude in effort to pursue a happy life was ...
(Date:7/31/2014)... The “Nucleic Acid Isolation and ... Magnetic bead based), Consumables & Instruments, by Application ... End users - Global Forecasts to 2018” provides ... challenges, opportunities, current market trends, and strategies impacting ... along with the estimates and forecasts of the ...
(Date:7/31/2014)... 2014 Ticket Down is a reputable ... in Santa Clara, California. Fans in the United States of ... the best club and national teams in the world. Coming off ... has become the best time to be a fan of soccer ... being held on American soil this year, as well as international ...
Breaking Medicine News(10 mins):Health News:Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk 2Health News:Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk 3Health News:Simple tips to fend off freak-outs 2Health News:Simple tips to fend off freak-outs 3Health News:Don't Forget To Mention Never Give Up 26 Foundation 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 2Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 3
... , MORRISTOWN, N.J., Aug. 28 Watson Pharmaceuticals, ... company, today announced that its subsidiary, Watson Laboratories, Inc., has ... Administration (FDA) on its Abbreviated New Drug Application (ANDA) for ... 17 and above, as well as for prescription use in ...
... risk, researchers say , FRIDAY, Aug. 28 (HealthDay News) ... flu puts 1.5 other people at risk over the three ... the conclusion of a new study published in the journal ... showing early symptoms of the flu needs to contact their ...
... , , DETROIT, ... The Parade Company will launch The Biggest Loser: Detroit Edition contest ... selected from approximately 200 applicants to compete in this 12-week weight ... "The Biggest Loser is one of the most popular programs, ...
... 28 Children,s Hospital of Pittsburgh of UPMC has been ... leader in its use of healthcare information technology among pediatric ... KLAS interviewed leaders at virtually every hospital in the United ... software to order and chart under an organized program sponsored ...
... FRIDAY, Aug. 28 (HealthDay News) -- Men, want to keep high ... the message from a Harvard study that found that whole grain ... health. Although this study is among men, data from the Women,s ... grains as a part of a prudent, balanced diet may help ...
... TSX: COM , , VANCOUVER, ... / TSX: COM) today announced that Dr. Christian Torp-Pedersen ... 2b clinical trial of vernakalant (oral) at the European ... Barcelona, Spain from August 29 to September 2, 2009. ...
Cached Medicine News:Health News:Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use 2Health News:Study Details Swine Flu Transmission Rates 2Health News:Study Details Swine Flu Transmission Rates 3Health News:WDIV-TV, Blue Cross Blue Shield of Michigan and The Parade Company Help Launch The Biggest Loser: Detroit Edition 2Health News:Children's Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 2Health News:Children's Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 3Health News:Whole Grains, Bran May Fight Hypertension in Men 2Health News:Whole Grains, Bran May Fight Hypertension in Men 3Health News:Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009 2Health News:Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009 3
(Date:7/31/2014)... 31, 2014 Lazarus Effect, a medical device ... to facilitate removal of blood clots, announced the closing ... will support EU commercialization of several approved Lazarus Effect ... ReCover™ and Lazarus Cover™ in the United ... confidence in the value of our novel, platform technology ...
(Date:7/31/2014)... and VIENNA , July 31, ... a press conference in New York ... a vaccine against Parkinson,s disease. PD01A is the first therapy ... enter clinical testing. The Michael J. Fox Foundation ... 1.5 million grant, and presented at the press conference on ...
(Date:7/31/2014)... NORTHBROOK, Ill. , July 31, 2014 /PRNewswire/ ... as the head of corporate and employee communications ... to Jeff Winton , senior vice president, ... be responsible for developing and leading corporate brand ... business goals across North and South ...
Breaking Medicine Technology:Lazarus Effect Closes $5 Million Financing 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2
... ... research and biotechnology companies are testing 97 medicines and vaccines to ... report released today by the Pharmaceutical Research and Manufacturers of America ... - a global awareness campaign that originated at the 1988 World ...
... , XI,AN, China, Nov. ... a leading developer and producer,of plant extracts and pharmaceutical raw ... China, today reported that in its,third quarter, the company realized ... Revenues for the quarter ended Sept. 30, 2009 were $4,465,770, ...
Cached Medicine Technology:New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 4
7 mm curved blade. Round handle....
7 mm strong curved blade. Round handle....
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
No. 4. 0.75 mm wide x 5 mm long, lightly curved tip, offset to the left. Hexagonal handle....
Medicine Products: